Currently predicting for Thu, 4 Jun 2026

LLY Prediction Chart

LLY Predictions History

Latest community submissions for LLY.
Predictor Target Session Target Price Result Direction Accuracy Score
Dec 11, 2023 Bullish $584.04 X 0
Nov 10, 2023 $583.26 -1.36% $597.71 X 97.58% 0
Nov 10, 2023 $586.28 -0.85% $597.71 X 98.09% 0
Oct 19, 2023 $613.28 +1.00% $590.80 X 96.19% 0
Oct 19, 2023 $603.46 -0.62% $590.80 V 97.86% 1
Oct 19, 2023 Bullish $590.80 X 0
Aug 28, 2023 $548.97 -0.85% $553.92 X 99.11% 2
Aug 28, 2023 $550.73 -0.53% $553.92 X 99.42% 3
Aug 28, 2023 $447.00 -19.26% $553.92 X 80.70% 0
Neill McAuliffe Neill McAuliffe @NeillMcAuliffe.129203
Aug 28, 2023 Bullish $553.92 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LLY with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ELI LILLY AND COMPANY
Eli Lilly
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE